Skip to content

Comparative study between normals and patients with problems at the back of their eye and its relationship with stress

Comparison of Optical Coherence Tomography features and Anxiety Scores in patients with Central Serous Chorioretinopathy versus Controls.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029931
Enrollment
128
Registered
2020-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H32- Chorioretinal disorders in diseases classified elsewhere Health Condition 2: H579- Unspecified disorder of eye and adnexa

Interventions

Intervention1: Central Serous Chorioretinopathy Patients: Treatment naïve cases with first episode of CSCR presenting to the Retina Services at Aravind Eye Hospital Pondicherry Control Intervention1:

Sponsors

Aravind Eye Hospital Pondicherry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Group A: Treatment naïve cases with first episode of CSCR presenting to the Retina Services at Aravind Eye Hospital Pondicherry Patients willing to give informed written consent Presenting within the age group of 18-55 years Group B: Controls who are age and gender matched visiting Aravind eye hospital for eye exam Nil systemic illness Anterior segment â?? no vision threatening pathology. Cataract Nil/LC/NS1 or PCIOL with no PCO Having a normal fundus Refractive error within +2 D to â?? 2 D spherical equivalent Patients willing to give informed written consent

Exclusion criteria

Exclusion criteria: Patients with any other ocular pathology. Children and adolescents below 18 years Adults above 55 years.

Design outcomes

Primary

MeasureTime frame
In CSCR the pachychoroid spectrum maybe more as compared to controls The stress and anxiety risk factors are also maybe more in CSCR compared to normal controls The OCT findings will be well defined and confirm the characteristics of pachychoroid disease spectrum Timepoint: At Baseline (Day 0)

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Manavi D Sindal

Aravind Eye Hospital Pondicherry

manavi@aravind.org9884081417

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026